拖动LOGO至书签栏，立即收藏博途智库
PublishedbyTheResourceCentre,anIPANAssociateDisclaimer:Thematerialisbaseduponinformationweconsiderreliableanditisupdatedtothebestofourability,butwedonotrepresentthatitisaccurateorcomplete,anditshouldnotberelieduponassuch.Forprivatecirculationonly1PharmaDECEMBER,2002REVIEWPharmasalesfallDomesticsalesofPharmaceuticalproductsshowedaslowdowninOctoberthisyear,registeringa2.6percentgrowthagainst4.6pe...
ThisdocumenthasbeenpreparedbyInvestsmartIndiaLtd.(theCompany)andisbeingdistributedinIndiabytheCompany,aregisteredbroker-dealer.Theinformationandopinionscontainedinthedocumenthavebeencompiledfromsourcesbelievedtobereliable.Thecompanydoesnotwarrantitsaccuracy,completenessandcorrectness.Thisdocumentisnot,andshouldnotbeconstruedas,anoffertosellorsolicitationtobuyanysecurities.Thisdocumentmaynotbere...
GThePharmaceuticalindustryisregulatedworldwideintermsofpatents,priceandproductquality.GInternationalpatentnormsrecogniseproductpatents,andthesenormswouldbebindingonallsignatoriestotheGeneralAgreementonTariffsandTrade(GATT),includingIndia,accordingtothestipulationundertheWorldTradeOrganisation(WTO—thesuccessortoGATT).GIndiarecognisesprocesspatents(asopposedtoproductpatents)undertheIndianPatentA...
Page165ANNEXURESTHEINDIANPharmaCEUTICALINDUSTRYAnnexure1HEALTHCAREINFRASTRUCTUREDISEASEPROFILEININDIAHealthcareInfrastructureThehealthcaresectorinacountryincludesnotonlythedrugsandPharmaceuticalsindustrybutalsothedeliverysystemthatmakesdrugsavailabletothepatient.Thedeliverysystemincludesdoctors,chemists,hospitalsandhealthcarerelatedservices.Ithasbeenobservedthatwithanincreaseinthepenetrationofh...
GThePharmaceuticalmarketcanbedividedintodifferenttherapeuticsegmentsonthebasisofapplication.Therelativesharesofthevarioustherapeuticsegmentsdepend,toagreatextent,onthelevelofeconomicdevelopment,diseaseincidenceandtheavailabilityofhealthcareinfrastructureinacountry.InIndia,anti-infectivesaccountforthelargestmarketshareofabout26%.GThemarketforPharmaceuticalproductsisbroadlydividedintotheethicalse...
GThesizeoftheIndianPharmaceuticalindustryisestimatedatRs.231billion,growingattheannualrateof17%(compoundedannualgrowthrateforFY1996-2001).GTheIndianPharmaceuticalindustryisthefourthlargestgloballyinvolumeterms,andisalmostself-sufficient.However,thegrowthinthebulkdrugssegmenthasbeenhigherthanthatinformulations,primarilybecauseofexports.GTherearearound20,053playersintheIndianPharmaceuticalindustr...
CORPORATEDIGESTIIPartICRAINDUSTRYWATCHSERIESPage214ALEMBICLIMITEDStockChartvaluedofRs.100investedinSensexandCompanyFinancialIndicatorsSector:ValueManufacturingMarketcap:808(Rsmn)Turnover:4739(Rsmn)TotalReturns(%)21.8TotalAssets:3909(Rsmn)ROCE(%)21.7InterimResultsFaceValue10.0MarketPrice11252WkH/L145/60.25BkClsdate30/6/2001P/Eratio3.4FinancialHighlightsListings:NSE,BSE,RegionalFY2002FY2001QTR4QT...
ICRAInformationServicesICRAInformationServicesICRAInformationServicesICRAInformationServicesADivisionofICRALimitedwww.icraindia.comSeptember2002ICRASectorResearchICRASectorResearchICRASectorResearchICRASectorResearchIndustryCommentIndustryCommentIndustryCommentIndustryCommentTheIndianPharmaceuticalIndustryDDDDRUGSANDRUGSANDRUGSANDRUGSANDPPPPharmaCEUTICALSHARMACEUTICALSHARMACEUTICALSHARMACEUTICA...
